Chenodeoxycholic acid

Therapeutic Indications

Chenodeoxycholic acid is indicated for:

Sterol 27 hydroxylase deficiency, cerebrotendinous xanthomatosis (CTX)

Irrespective of gender only Adults (18 - 65 years old)

Chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (CTX)) in infants, children and adolescents aged 1 month to 18 years and adults.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 750 mg in 3 divided doses daily

Sterol 27 hydroxylase deficiency, cerebrotendinous xanthomatosis (CTX)

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old) , Adolescents (12 years - 18 years old)

Chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (CTX)) in infants, children and adolescents aged 1 month to 18 years and adults.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 5 mg/kg in 3 divided doses daily